NR2F1 and prostate carcinoma: In addition, a number of established quiescence mechanisms are conserved across cancer types; for example, increased p38:ERK signalling ratio, NR2F1 and p27 have all been shown to be dormancy-inductive in head and neck squamous cell carcinoma, breast and prostate cancers [52,53,54,55,56].